166 related articles for article (PubMed ID: 2265473)
1. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
[TBL] [Abstract][Full Text] [Related]
2. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Cancer Lett; 1991 Jul; 59(1):45-50. PubMed ID: 1878860
[TBL] [Abstract][Full Text] [Related]
3. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.
Pour PM; Lawson T; Helgeson S; Donnelly T; Stepan K
Carcinogenesis; 1988 Apr; 9(4):597-601. PubMed ID: 2833367
[TBL] [Abstract][Full Text] [Related]
4. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
[TBL] [Abstract][Full Text] [Related]
5. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
Ogura Y; Matsuda S; Itho M; Sasaki H; Tanigawa K; Shimomura M
World J Surg; 2002 Mar; 26(3):359-65. PubMed ID: 11865375
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
Howatson AG; Carter DC
Br J Cancer; 1985 Jan; 51(1):107-14. PubMed ID: 3966964
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of biliary carcinogenesis in hamsters by cholecystokinin.
Ikematsu Y; Tomioka T; Tajima Y; Tsunoda T; Kanematsu T
World J Surg; 1995; 19(6):847-50; discussion 850-1. PubMed ID: 8553677
[TBL] [Abstract][Full Text] [Related]
10. Effects of catechol and its analogs on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters.
Maruyama H; Amanuma T; Nakae D; Tsutsumi M; Kondo S; Tsujiuchi T; Denda A; Konishi Y
Carcinogenesis; 1991 Jul; 12(7):1331-4. PubMed ID: 2070500
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor.
Chester JF; Gaissert HA; Ross JS; Malt RA
Cancer Res; 1986 Jun; 46(6):2954-7. PubMed ID: 3009003
[TBL] [Abstract][Full Text] [Related]
12. Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
Herrington MK; Permert J; Kazakoff KR; Zucker KA; Bilchik AJ; Pour PM; Adrian TE
Cancer Lett; 1994 Jul; 82(1):7-16. PubMed ID: 8033071
[TBL] [Abstract][Full Text] [Related]
13. Effects of sandostatin, alone and in combination with surgical castration, on pancreatic carcinogenesis in rats and hamsters.
Visser CJ; van Garderen-Hoetmer A; Klijn JG; Foekens JA
Int J Cancer; 1996 Mar; 65(6):827-32. PubMed ID: 8631599
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.
Furukawa F; Nishikawa A; Imaida K; Mitsui M; Enami T; Hayashi Y; Takahashi M
Carcinogenesis; 1992 Nov; 13(11):2133-5. PubMed ID: 1330352
[TBL] [Abstract][Full Text] [Related]
15. Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters.
Furukawa F; Nishikawa A; Imazawa T; Kasahara K; Takahashi M
Jpn J Cancer Res; 1998 Feb; 89(2):131-6. PubMed ID: 9548439
[TBL] [Abstract][Full Text] [Related]
16. Promoting effect of truncal vagotomy on pancreatic carcinogenesis initiated with N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters.
Ogawa T; Makino T; Mizumoto K; Nakayama F
Carcinogenesis; 1991 Jul; 12(7):1227-30. PubMed ID: 2070487
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive activity of Oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters.
Clapper ML; Wood M; Leahy K; Lang D; Miknyoczki S; Ruggeri BA
Carcinogenesis; 1995 Sep; 16(9):2159-65. PubMed ID: 7554069
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3-aminobenzamide on the post-initiation phase of N-nitrosobis(2-oxopropyl)amine induced pancreatic carcinogenesis in Syrian hamsters.
Tsujiuchi T; Mizumoto K; Tsutsumi M; Denda A; Amanuma T; Kondoh S; Konishi Y
Cancer Lett; 1991 Dec; 61(1):61-6. PubMed ID: 1764698
[TBL] [Abstract][Full Text] [Related]
19. Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure.
Povoski SP; Fenoglio-Preiser CM; Sayers HJ; McCullough PJ; Zhou W; Bell RH
Carcinogenesis; 1993 May; 14(5):961-7. PubMed ID: 8504490
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
